Is Journey Medical Corp. overvalued or undervalued?

Sep 20 2025 06:36 PM IST
share
Share Via
As of November 12, 2024, Journey Medical Corp. is considered a risky investment due to its overvaluation and poor financial metrics, including a Price to Book Value of 7.99 and a negative EV to EBITDA ratio of -22.82, despite a strong year-to-date return of 85.93%.
As of 12 November 2024, the valuation grade for Journey Medical Corp. has moved from fair to risky, indicating a deteriorating outlook. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 7.99 and a troubling EV to EBITDA ratio of -22.82. Additionally, the Return on Capital Employed (ROCE) stands at -44.88%, reflecting significant inefficiencies in generating returns from capital investments.

In comparison to peers, Journey Medical Corp.'s valuation ratios are less favorable; for instance, Fortress Biotech, Inc. has a more manageable EV to EBITDA of -0.87, while Sol-Gel Technologies Ltd. shows an EV to EBITDA of -11.11. Despite the company's strong year-to-date return of 85.93% compared to the S&P 500's 12.22%, the overall financial health suggests that the stock is not a sound investment at its current price of 7.27.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News